Search results for "Arginine vasopressin receptor 1B"

showing 3 items of 3 documents

Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens

1998

We studied the effects of vasopressin on the adrenergic responses of in vitro preparations of circular muscle from the vas deferens obtained from 28 men undergoing elective vasectomy. Vasopressin (3 x 10(-9)-3 x 10(-8) M) enhanced the phasic contractions elicited by electrical field stimulation and noradrenaline. This potentiation was blocked by the vasopressin V1 receptor antagonist d(CH2)5Tyr(Me)vasopressin (10(-6) M) but not by the vasopressin V2 receptor antagonist [d(CH2)5, D-Ile2,Ile4,Arg8]vasopressin (10(-6) M). The Ca2+ antagonist nifedipine (10(-6) M) did not affect the potentiation of electrical field stimulation induced by vasopressin and noradrenaline but reduced KCl-induced con…

AdultMaleReceptors Vasopressinmedicine.medical_specialtyVasopressinNifedipineVasopressinsNeuropeptideAdrenergicStimulationIn Vitro TechniquesSynaptic TransmissionPotassium ChlorideNorepinephrineHormone AntagonistsVas DeferensInternal medicinemedicineHumansVasoconstrictor AgentsVasopressin receptorPharmacologyArginine vasopressin receptor 1BChemistryAntagonistVas deferensMuscle SmoothCalcium Channel BlockersElectric StimulationArginine Vasopressinmedicine.anatomical_structureEndocrinologyAdrenergic alpha-AgonistsAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsMuscle ContractionEuropean Journal of Pharmacology
researchProduct

Structural requirements for V2 vasopressin receptor proteolytic cleavage.

1999

The ligand-induced proteolytic cleavage of the V2 vasopressin receptor transiently expressed in COS cells was investigated. After incubation of the cell membranes with a photoreactive ligand possessing full agonistic properties for V2 receptors, approximately 90% of the porcine and bovine V2 vasopressin receptors were cleaved in the upper part of transmembrane helix 2 at a heptapeptide sequence conserved in both vasopressin and oxytocin receptors. The oxytocin receptor was completely resistant to proteolysis after binding the same photoreactive ligand, which is only a partial agonist for this receptor. Chimeric V2/oxytocin receptors obtained by transfer of extracellular domains of the oxyto…

Models MolecularReceptors VasopressinDNA ComplementaryTime FactorsProtein ConformationSwineMolecular Sequence DataBiologyLigandsTransfectionBiochemistryArginine vasopressin receptor 2Enzyme-linked receptorCyclic AMPAnimalsHumansPoint Mutation5-HT5A receptorAmino Acid SequenceCloning MolecularReceptorProtease-activated receptor 2Vasopressin receptorArginine vasopressin receptor 1BDose-Response Relationship DrugSequence Homology Amino AcidProteinsOxytocin receptorProtein Structure TertiaryEnzyme ActivationBiochemistryMicroscopy FluorescenceReceptors OxytocinType C PhospholipasesCOS CellsMutagenesis Site-DirectedCattlehormones hormone substitutes and hormone antagonistsAdenylyl CyclasesProtein BindingEuropean journal of biochemistry
researchProduct

Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congenital nephrogenic diabetes insipidus.

2000

Vasopressin V2 receptor mutants from three different patients with congenital nephrogenic diabetes insipidus phenotypes were investigated after expression in COS cells. The amino acid exchanges within the human V2 receptor are located in the second extracellular loop (T204N, Y205C and V206D). Confocal microscopy showed that all receptor mutants were strongly expressed but mainly located within the cell. Residual binding capacity for the antidiuretic hormone arginine vasopressin (AVP) could only be detected for the T204N mutant and was 10-fold lower than for the wild-type receptor. Stimulation of transfected cells with 1 microM AVP showed that the T204N mutant was able to activate the adenyl…

Receptors Vasopressinmedicine.medical_specialtyVasopressinVasopressinsDiabetes Insipidus NephrogenicBiologyTransfectionBiochemistryCell LineEndocrinologyInternal medicineArginine vasopressin receptor 2medicineHumansReceptorMolecular BiologyVasopressin receptorArginine vasopressin receptor 1BElucidation of the molecular defect responsible for congenital nephrogenic diabetes insipidus (NDI)Nephrogenic diabetes insipidusmedicine.diseaseEndocrinologyMutationOpheldering van het moleculaire defect dat verantwoordelijk is voor congenitale nefrogene diabetes insipidus (NDI)cAMP-dependent pathwayhormones hormone substitutes and hormone antagonistsSignal TransductionAntidiuretic
researchProduct